Sanara MedTech
Update in progressSMTI (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Instruments & Supplies
Sanara MedTech Inc. is a Fort Worth, Texas-based medical technology company that develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care providers in the United States. Its portfolio includes CellerateRX Surgical, a bovine collagen hydrolysate for wound management; BIASURGE and BIASURGE Advanced Surgical Solution; FORTIFY TRG; BiFORM; ACTIGEN; ALLOCYTE Plus; and TEXAGEN. It licenses Rochal antimicrobial products.
Company score
- Sentiment
- 0.00
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.02
- Governance
- 0.06
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.01
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.00
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Seth D. Yon
- Founded2001
- Employees108
- Websitesanaramedtech.com
Identifiers
- ISINUS79957L1008
- FIGIBBG000KLGDZ6
- CUSIP832688204
- CIK0000714256